ING

Erste Group Bank kept the tap open on subordinated supply in the euro market this week with a €500m 11-year non-call six deal.

Rentenbank plans to issue its first green bond in the middle of September, after two weeks of meetings and calls with investors. Treasurer Stefan Goebel said he was not too concerned by the impending wave of supply from the European Commission.

European banks spied further opportunities in the dollar market this week, even as many in the sector turned their attentions back to their home currency.

Communauté Française de Belgique returned in mid-August after a seventh month absence to print a slew of deals for a combined €404m, according to Dealogic.

Kim Balt, who led ING's equity syndicate desk for 18 years, has joined Avantium, a Dutch company that makes alternatives to plastics from plants.

Ista, the German energy company, has signed a €1.85bn sustainability-linked loan, as interest in this structure among European companies returns to near pre-crisis levels.

Ista, the German energy company, has signed a €1.85bn sustainability-linked loan, as European corporates considering the ESG-linked structure nears pre-crisis levels.

Spain’s Sonnedix, a solar power producer, has signed bank facilities totalling €154m, a day after Moody’s said sustainable project finance has a lower default risk than its conventional equivalent.

Royal Bam group, the Dutch construction company, has negotiated a waiver on its loan covenants before they were due to be tested this week. Some loans bankers say that similar agreements are expected to be made across multiple industries for the rest of the year.

Northvolt, the Swedish battery maker, has signed a $1.6bn credit facility. A range of lenders — from commercial to governmental — piled into the deal, which will effectively create a new industry in Europe.

Phoenix Pharmahandel, the German pharmaceutical company, issued a five year euro-denominated bond on Wednesday, as pharma companies across the credit spectrum continue to hold investors’ attention.

German pharmaceutical company, Phoenix Pharmahandel (Phoenix Group), held investor calls on Monday after mandating banks for a sub-benchmark sized offering in euros. The deal is the latest stab at funding by a pharmaceutical company — a sector which has lured greater numbers of investors thanks to the coronavirus pandemic.